Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Sham Tms

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Early Phase 1 (1)

Trial Status

Completed1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06830980Not ApplicableCompletedPrimary

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

NCT06695637Early Phase 1Withdrawn

Individualized Neuromodulation of Craving Control for Meth Use Disorders

Showing all 2 trials

Research Network

Common Treatments

  • Sham Tms1
  • Active Ctbs1
  • Intermittent Theta Burst Stimulation Itbs1
  • Sham Ctbs1
  • Continuous Theta Burst Stimulation Ctbs1

Active Sponsors

  • National Center for Advancing Translational Sciences (NCATS)1
  • University of Minnesota1
  • Gopalkumar Rakesh1

Top Investigators

Related Conditions

  • Substance Use Disorders1
  • Hiv1

Activity Timeline